Asco 2025 · Posters · Cáncer de Pulmón · Valentina Gambardella, MD, PhyD Volver

Debio 0123, a highly selective WEE1 inhibitor, in combination with carboplatin (C) and etoposide (E), in patients (pts) with recurrent small cell lung cancer (SCLC): Determination of recommended dose (RD) from a phase 1 escalation.

Abstract: 8098
Poster Bd #: 219
Descargar Poster

Valentina Gambardella, MD, PhyD

Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia.

Una iniciativa científica de: Eco Logo
Clover sgm Logo
Con el patrocinio de: Regeneron Logo